Metformin Can Reduce the Risk of Parkinson's Disease, Monash University Study
The 12-year study based on a Taiwanese population cohort looked at the effect of sulfonylureas with metformin in individuals with diabetes. It was found that not only does diabetes increase the risk of developing Parkinson’s disease more than two-fold, the use of sulfonylureas, commonly used to stimulate the beta cells to produce more insulin, increases the risk by about 57 per cent.